Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice
- 1 August 1991
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (2) , 221-226
- https://doi.org/10.1038/bjc.1991.280
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Reversal by Two Dihydropyridine Compounds of Resistance to Multiple Anticancer Agents in Mouse P388 Leukemia in vivo and in vitroJapanese Journal of Cancer Research, 1990
- Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoproteinBiochemical Pharmacology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activityCancer Chemotherapy and Pharmacology, 1989
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- DETECTION OF A MULTIDRUG RESISTANT PHENOTYPE IN ACUTE NON-LYMPHOBLASTIC LEUKAEMIAThe Lancet, 1987
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987
- Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.Proceedings of the National Academy of Sciences, 1986